CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7 enrolled
Drug / intervention
bupropion +5 moredrug
Likely dose
transdermal nicotine patch 7 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02869451
NCT02869451N/ACompleted

Mobile Contingency Management for Concurrent Abstinence From Cannabis and Cigarette Smoking: A Pilot Study

Duke University·interventional·Posted Aug 17, 2016·Updated Feb 7, 2020

In Brief

A clinical study evaluating bupropion, transdermal nicotine patch, and 4 other interventions for Cigarette Smoking and Marijuana Abuse. Completed, enrolled 7 participants across 1 site.

Detailed Summary

The purpose of this pilot project is to pilot-test a combined cannabis and smoking cessation treatment. The intervention combines mobile technology with behavioral strategies, counseling, and medications.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedAug 17, 2016
Enrollment StartAug 1, 2016
Primary CompletionMay 17, 2017
TodayJul 2, 2026
Enrollment to primary: 10 monthsPosted 9.9 years ago

Interventions

bupropiondrug

Prescribed one week prior to quit and continued until the 6 month follow-up visit.

transdermal nicotine patchdrug

Initiated at smoking quit date; 7 mg to 21 mg patch depending on amount smoked by participant

Nicotine polacrilexdrug

Initiated at smoking quit date.

nicotine lozengedrug

Initiated at smoking quit date.

counseling for marijuana and smoking cessationbehavioral

5 sessions of cognitive-behavioral counseling designed to facilitate marijuana and smoking cessation and promote relapse prevention

mobile contingency managementbehavioral

treatment that provides money rewards for abstinence from smoking and marijuana